Pitt Shield

Resting State Functional Connectivity Signatures of MRgFUS Vim Thalamotomy in Parkinson's Disease: A Preliminary Study.

Authors: Stanziano M, Golfrè Andreasi N, Messina G, Rinaldo S, Palermo S, Verri M, Demichelis G, Medina JP, Ghielmetti F, Bonvegna S, Nigri A, Frazzetta G, D'Incerti L, Tringali G, DiMeco F, Eleopra R, Bruzzone MG

Magnetic Resonance-guided high-intensity Focused Ultrasound (MRgFUS) of the thalamic ventral intermediate nucleus (Vim) for tremor has increasingly gained interest as a new non-invasive alternative to standard neurosurgery. Resting state functional connectivity (rs-FC) correlates of MRgFUS have not been extensively investigated yet. A region of interest (ROI)-to-ROI rs-FC MRI "connectomic" analysis focusing on brain regions relevant for tremor was conducted on 15 tremor-dominant patients with Parkinson's disease who underwent MRgFUS. We tested whether rs-FC between tremor-related areas was modulated by MRgFUS at 1 and 3 months post-operatively, and whether such changes correlated with individual clinical outcomes assessed by the MDS-UPDRS-III sub items for tremor. Significant increase in FC was detected within bilateral primary motor (M1) cortices, as well as between bilateral M1 and crossed primary somatosensory cortices, and also between pallidum and the dentate nucleus of the untreated hemisphere. Correlation between disease duration and FC increase at 3 months was found between the putamen of both cerebral hemispheres and the Lobe VI of both cerebellar hemispheres, as well as between the Lobe VI of untreated cerebellar hemisphere with bilateral supplementary motor area (SMA). Drop-points value of MDS-UPDRS at 3 months correlated with post-treatment decrease in FC, between the anterior cingulate cortex and bilateral SMA, as well as between the Lobe VI of treated cerebellar hemisphere and the interpositus nucleus of untreated cerebellum. Tremor improvement at 3 months, expressed as percentage of intra-subject MDS-UPDRS changes, correlated with FC decrease between bilateral occipital fusiform gyrus and crossed Lobe VI and Vermis VI. Good responders (≥50% of baseline tremor improvement) showed reduced FC between bilateral SMA, between the interpositus nucleus of untreated cerebellum and the Lobe VI of treated cerebellum, as well as between the untreated SMA and the contralateral putamen. Good responders were characterized at baseline by crossed hypoconnectivity between bilateral putamen and M1, as well as between the putamen of the treated hemisphere and the contralateral SMA. We conclude that MRgFUS can effectively modulate brain FC within the tremor network. Such changes are associated with clinical outcome. The shifting mode of integration among the constituents of this network is, therefore, susceptible to external redirection despite the chronic nature of PD.

Introduction

Purpose Thermal ablation
Study Objective To determine whether MRgFUS Vim ablation in tremor-dominant Parkinson's disease modulates resting-state functional connectivity within the tremor network at 1 and 3 months post-treatment and whether these changes correlate with clinical outcomes.
Animal model / Human subject Human (Homo sapiens; tremor-dominant Parkinson's disease patients, n=15), strain: N/A, age: mean age 64 years old, sex: not specified
Disease model Parkinson's disease
MRI or image guidance method Magnetic Resonance-guided (MRgFUS)
Targeted brain region(s) Thalamic Ventral Intermediate Nucleus (Vim)

Outcomes and Safety

Summary of Outcomes Unilateral MRgFUS Vim thalamotomy in tremor-dominant Parkinson's patients modulated resting-state functional connectivity across the tremor network — notably increasing interhemispheric M1 and M1–S1 coupling, dentate–pallidal and cerebellar–putamen/SMA connectivity — and these FC changes correlated with clinical tremor improvement at 1 and 3 months. Good responders were characterized by pre-treatment hypoconnectivity between putamen and M1/SMA and showed distinct post-treatment FC reorganization; the study did not compare multiple focused-ultrasound parameter sets.
Duration of biological effect 3 months
Safety-related matter The authors state MRgFUS has been demonstrated to be safe and effective and note that clinical effects and any potential adverse events can be promptly assessed; in this study all patients successfully completed MRgFUS and no adverse events or complications are reported.

Brain Region

Ultrasound Parameters

Ultrasound instrument ExAblate 4000 system (InSightec, Haifa, Israel)
Focal Characteristics Focal depth: None; Focal length: None; Aperture size: None
Treatment frequency single

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search